COVID-19 or not COVID-19? Compared characteristics of patients hospitalized for suspected COVID-19.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 04 10 2020
accepted: 01 03 2021
pubmed: 10 3 2021
medline: 17 8 2021
entrez: 9 3 2021
Statut: ppublish

Résumé

During an epidemic period, we compared patients hospitalized for initial suspicion of COVID-19 but for whom an alternative diagnosis was finally retained (n = 152) with those who had COVID-19 (n = 222). Most common diagnoses were another infectious disease and heart failure. COVID-19-negative patients were more often active smokers had less often cough, fever, and digestive symptoms, as compared to the 222 COVID-19-positive patients. They had higher median neutrophil and lymphocyte counts and lower CRP level. In multivariate analysis, no current smoking, neurocognitive disorder, myalgia, and fibrinogen ≥4g/L were independently associated with a final diagnosis of COVID-19.

Identifiants

pubmed: 33686557
doi: 10.1007/s10096-021-04216-3
pii: 10.1007/s10096-021-04216-3
pmc: PMC7939542
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2023-2028

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Eur Respir J. 2020 Jul 16;56(1):
pubmed: 32430431
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
Mayo Clin Proc. 2020 Jun;95(6):1222-1230
pubmed: 32376099
Eur Respir J. 2020 May 14;55(5):
pubmed: 32269089
Nat Med. 2020 Jul;26(7):1037-1040
pubmed: 32393804
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Br J Radiol. 2020 Aug;93(1112):20200243
pubmed: 32450727
Eur J Intern Med. 2020 May;75:107-108
pubmed: 32192856
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Dev Cell. 2020 Jun 8;53(5):514-529.e3
pubmed: 32425701
J Infect. 2020 Sep;81(3):e99-e100
pubmed: 32416124
Postgrad Med J. 2020 Jul;96(1137):387-391
pubmed: 32434874
Respir Med. 2020 Jul;168:105980
pubmed: 32364959
Rev Med Interne. 2020 May;41(5):308-318
pubmed: 32334862
J Med Virol. 2020 Oct;92(10):1915-1921
pubmed: 32293753
Eur J Intern Med. 2020 Jul;77:123-124
pubmed: 32439289

Auteurs

Thomas Rogier (T)

Infectious Diseases Department, Dijon Bourgogne University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France. thomas.rogier@chu-dijon.fr.

Isabelle Eberl (I)

Infectious Diseases Department, Dijon Bourgogne University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.

Florian Moretto (F)

Infectious Diseases Department, Dijon Bourgogne University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.

Thibault Sixt (T)

Infectious Diseases Department, Dijon Bourgogne University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.

François-Xavier Catherine (FX)

Infectious Diseases Department, Dijon Bourgogne University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.

Clémentine Estève (C)

Infectious Diseases Department, Dijon Bourgogne University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.

Maroua Abdallahoui (M)

Infectious Diseases Department, Dijon Bourgogne University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.

Lucile Behague (L)

Infectious Diseases Department, Dijon Bourgogne University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.

Antoine Coussement (A)

Infectious Diseases Department, Dijon Bourgogne University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.

Lucas Mathey (L)

Infectious Diseases Department, Dijon Bourgogne University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.

Sophie Mahy (S)

Infectious Diseases Department, Dijon Bourgogne University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.

Marielle Buisson (M)

Infectious Diseases Department, Dijon Bourgogne University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.

Arnaud Salmon-Rousseau (A)

Infectious Diseases Department, Dijon Bourgogne University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.

Michel Duong (M)

Infectious Diseases Department, Dijon Bourgogne University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.

Pascal Chavanet (P)

Infectious Diseases Department, Dijon Bourgogne University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.

Quentin Bernard (Q)

Department of Clinical Nephrology, Dijon Bourgogne University Hospital, Dijon, France.

Barbara Nicolas (B)

Department of Internal Medicine and Clinical Immunology, Dijon Bourgogne University Hospital, Dijon, France.

Leila Benguella (L)

Department of Rheumatology, Dijon Bourgogne University Hospital, Dijon, France.

Bernard Bonnotte (B)

Department of Internal Medicine and Clinical Immunology, Dijon Bourgogne University Hospital, Dijon, France.
Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-21000, Dijon, France.

Mathieu Blot (M)

Infectious Diseases Department, Dijon Bourgogne University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.
Univ. Bourgogne Franche-Comté, LNC UMR1231, F-21000, Dijon, France.
INSERM, LNC UMR 1231, FCS Bourgogne-Franche Comté, LipSTIC LabEx, F-21000, Dijon, France.

Lionel Piroth (L)

Infectious Diseases Department, Dijon Bourgogne University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.
Univ. Bourgogne Franche-Comté, LNC UMR1231, F-21000, Dijon, France.
INSERM, LNC UMR 1231, FCS Bourgogne-Franche Comté, LipSTIC LabEx, F-21000, Dijon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH